The Cancer Grand Challenges Program Awards $100 Million To Four Research Teams
The National Cancer Institute, part of the National Institutes of Health, announced that four international research teams had been selected to receive a total of $100 million as part of the Cancer Grand Challenges program.
[Haematologica] Myeloid-derived suppressor cells (MDSCs) populations were evaluated in acquired aplastic anemia in which aberrant immune mechanisms contributed to bone marrow destruction.
[Cell Death & Disease] To investigate the effect of ellagic acid (EA) on benign prostate hyperplasia, scientists used EA, a phytochemical abundant in fruits and vegetables, to treat testosterone propionate-induced BPH rats and RWPE-1 human prostate epithelial cells.